Dr. Chaitanya Shah, M.D.
What this data tells you about Dr. Shah
Dr. Chaitanya Shah is an interventional cardiology in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Shah performed 3,489 Medicare services across 1,794 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $5,039 from 23 pharmaceutical and/or device companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity | 694 | $64 | $200 |
| Office visit, established patient (30-39 min) | 598 | $95 | $275 |
| Electrocardiogram (EKG), 12-lead | 326 | $10 | $65 |
| Hospital follow-up visit, low complexity | 259 | $40 | $115 |
| Office visit, established patient (20-29 min) | 222 | $56 | $185 |
| EKG interpretation and report | 167 | $7 | $30 |
| Prothrombin time test (blood clotting) | 139 | $4 | $20 |
| Echocardiogram, transthoracic | 123 | $153 | $810 |
| Regadenoson injection (Lexiscan) for heart stress test | 120 | $42 | $98 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 107 | $17 | $60 |
| Hospital follow-up visit, high complexity | 103 | $95 | $290 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 89 | $50 | $350 |
| Initial hospital admission, moderate complexity | 80 | $101 | $400 |
| Initial hospital admission, high complexity | 70 | $138 | $550 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 64 | $109 | $1,656 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 61 | $346 | $2,000 |
| Injection of additional new drug or substance into vein | 61 | $12 | $75 |
| Injection of drug or substance into vein | 58 | $30 | $150 |
| New patient office visit (45-59 min) | 31 | $126 | $464 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 30 | $41 | $135 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $10 | $200 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 19 | $207 | $900 |
| Cardiac catheterization | 15 | $173 | $2,867 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $16 | $75 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $10 | $50 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Shah is a clinical cardiology specialist, with above-average Medicare volume (top 29% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with hospital follow-up visit, moderate complexity?
Does Dr. Shah receive payments from pharmaceutical companies?
How do Dr. Shah's costs compare to other interventional cardiologys in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology